SAS Output

14-DEC-2018 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1400-SCCA,Adv, Biomarker Master 1 Y 1 Specimen Submission   1848 398 167 74 18 4 07/08/2014 449 205
            1848 398 167 74 18 4      
 
    2 Y 17 S1400G   62 23 0 0 0 0      
        2 S1400A   160 0 0 0 0 0 07/08/2014    
        21 S1400F   124 111 64 37 9 1      
        25 S1400K   50 50 21 2 0 0      
        3 S1400B   53 0 0 0 0 0      
        4 S1400C   88 0 0 0 0 0      
        5 S1400D   92 0 0 0 0 0      
        6 S1400E   16 0 0 0 0 0      
        7 S1400I   700 45 0 0 0 0      
            1345 229 85 39 9 1      
 
    3 P 10 S1400I   13 5 0 0 0 0      
        18 S1400G   10 2 0 0 0 0      
        22 S1400F   25 22 10 1 0 0      
        8 S1400B   1 0 0 0 0 0 07/08/2014    
            49 29 10 1 0 0      
 
    4 P 23 S1400F   3 3 0 0 0 0 07/08/2014    
            3 3 0 0 0 0      
 
  S1400A-Non-Match: MEDI4736 1 N 1 MEDI4736 140 78 0 0 0 0 0 07/31/2014    
        2 Docetaxel   38 0 0 0 0 0      
            116 0 0 0 0 0      
 
    2 Y 3 MEDI4736 140 4 0 0 0 0 0 07/31/2014    
            4 0 0 0 0 0      
 
  S1400F-Non-Match: MEDI4736 + Tremelimumab 1 Y 1 MEDI4736 + Tremelimumab 132 48 44 27 15 4 0 11/30/2017 455 207
            48 44 27 15 4 0      
 
  S1400K-c-Met: ABBV-399 (Process II) 1 T 1 ABBV-399 (Process II) 44 28 28 13 1 0 0 03/16/2018 475 222
            28 28 13 1 0 0      
 
  S1619-Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 1 Y 1 Chemotherapy + Atezolizumab 28 7 7 7 3 1 1 07/16/2018 77 26
            7 7 7 3 1 1      
 
    2 Y 2 Surgery 28 1 1 1 1 0 0 07/16/2018    
            1 1 1 1 0 0      
 
Yes A081105-ALCHEMIST1, EGFR mut, Erlotinib 1 E Total Registrations   45 14 6 4 3 0 04/01/2015 497 250
            45 14 6 4 3 0      
 
  A151216-ALCHEMIST0 - screening 1 E Total Registrations   640 229 115 44 22 7 12/16/2014 491 250
            640 229 115 44 22 7      
 
  C30610-SCLC, Thoracic RT 1 E Total Registrations   56 1 0 0 0 0 05/14/2008 168 91
            56 1 0 0 0 0      
 
  E4512-ALCHEMIST2, ALK mut, Crizotinib 1 E Total Registrations   11 4 3 2 1 0 02/29/2016 482 249
            11 4 3 2 1 0      
 
  NRGCC003-SCLC, PCI or HA-PCI 1 E Total Registrations   4 0 0 0 0 0 10/20/2016 262 126
            4 0 0 0 0 0      
 
    2 E Total Registrations   4 0 0 0 0 0 10/20/2016    
            4 0 0 0 0 0      
 
No A151216-ALCHEMIST0 - screening 0 E Total Registrations   648 231 117 44 21 7 12/16/2014 491 250
            648 231 117 44 21 7      
 
  EA5142-ALCHEMIST3, Non-match, Nivolumab 1 E Total Registrations   78 48 29 10 2 0 08/03/2016 462 245
            78 48 29 10 2 0      
 
  EA5161-Lung, ED-SCLC, Cis/Carbo and Eto +/- Nivo 1 E Total Registrations   18 18 18 12 4 0 06/26/2018 265 126
            18 18 18 12 4 0      
 

14-DEC-2018 6:10

LUNG Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1619 Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 3 Maintenance 03-Nov-17
S1701 Thymic Adv, Carbo/Pac/Ram vs. Carbo/Pac 1 Randomization 09-Aug-18